Cite

HARVARD Citation

    Hansen, O. et al. (n.d.). EP-1229: Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC). Radiotherapy and oncology. pp. S663-. [Online]. 
  
Back to record